We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$7.14B
Cap. Flow %
-8.9%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734

Sector Composition

Rank Sector Weight
1 Technology 12.69%
2 Industrials 9.96%
3 Consumer Discretionary 8.03%
4 Healthcare 7.46%
5 Financials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCNO icon
3251
nCino
NCNO
$2.26B
-926,192
Closed -$13.9M
NEOG icon
3252
Neogen
NEOG
$2.61B
-62,104
Closed -$577K
NEU icon
3253
NewMarket
NEU
$8.62B
-3,542
Closed -$2.27M
NG icon
3254
NovaGold Resources
NG
$3.83B
-37,600
Closed -$339K
NGVC icon
3255
Vitamin Cottage Natural Grocers
NGVC
$637M
-19,109
Closed -$494K
NICE icon
3256
Nice
NICE
$5.87B
-38,957
Closed -$3.78M
NKTR icon
3257
Nektar Therapeutics
NKTR
$2.53B
-35,851
Closed -$2.58M
NMRA icon
3258
Neumora Therapeutics
NMRA
$306M
-57,642
Closed -$112K
NNN icon
3259
NNN REIT
NNN
$8.8B
-62,916
Closed -$2.64M
NOC icon
3260
CALL
Northrop Grumman
NOC
$78.3B
-500
Closed -$341K
NOK icon
3261
PUT
Nokia
NOK
$57B
-500,000
Closed -$4.02M
NPCE icon
3262
Neuropace
NPCE
$482M
-23,350
Closed -$307K
NRGV icon
3263
Energy Vault
NRGV
$691M
-299,249
Closed -$988K
NSA
3264
DELISTED
National Storage Affiliates Trust
NSA
-777,982
Closed -$29.4M
NSC icon
3265
CALL
Norfolk Southern
NSC
$78.8B
-2,700
Closed -$775K
NSIT icon
3266
Insight Enterprises
NSIT
$4.33B
-5,815
Closed -$390K
NSP icon
3267
Insperity
NSP
$2.02B
-79,114
Closed -$2.14M
NSSC icon
3268
Napco Security Technologies
NSSC
$1.36B
-27,984
Closed -$1.1M
NTLA icon
3269
Intellia Therapeutics
NTLA
$1.8B
-169,286
Closed -$2.17M
NUTX
3270
Nutex Health
NUTX
$1.27B
-2,510
Closed -$239K
NVMI
3271
Nova
NVMI
$12B
-16,848
Closed -$7.32M
NVTS icon
3272
Navitas Semiconductor
NVTS
$3.39B
-36,355
Closed -$694K
NWG icon
3273
NatWest
NWG
$74B
-16,717
Closed -$249K
NWS icon
3274
News Corp Class B
NWS
$18.7B
-7,745
Closed -$221K
OFIX icon
3275
Orthofix Medical
OFIX
$408M
-28,055
Closed -$322K

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.